Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | |
| Cash Flows From Operating Activities | |
| Net Income | -13,871 |
| Depreciation Amortization | 332 |
| Other Working Capital | 1,002 |
| Other Operating Activity | 276 |
| Operating Cash Flow | $-12,261 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -1,175 |
| PPE Investments | -102 |
| Other Investing Activity | 22 |
| Investing Cash Flow | $-1,255 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 8,159 |
| Other Financing Activity | -200 |
| Financing Cash Flow | $7,959 |
| Beginning Cash Position | 17,473 |
| End Cash Position | 11,916 |
| Net Cash Flow | $-5,557 |
| Free Cash Flow | |
| Operating Cash Flow | -12,261 |
| Capital Expenditure | -102 |
| Free Cash Flow | -12,363 |